[PDF][PDF] A szérum fetuin-A szerepének vizsgálata anyagcsere és immunmediált betegségekben

B Márkus - 2023 - repo.lib.semmelweis.hu
Az evolúció során nagyfokban konzervált multifunkcionális molekula biológiai szerepe
lassan körvonalazódik: mineral chaperonként elősegíti a kalcium és a foszfor beépülését a …

[HTML][HTML] Tissue chaperoning—the expanded functions of fetuin-A beyond inhibition of systemic calcification

S Rudloff, W Jahnen-Dechent, U Huynh-Do - Pflügers Archiv-European …, 2022 - Springer
Traditionally, fetuin-A embodies the prototype anti-calcification protein in the blood,
preventing cardiovascular calcification. Low serum fetuin-A is generally associated with …

Fetuin-A–Alpha2-Heremans-Schmid Glycoprotein: From Structure to a Novel Marker of Chronic Diseases Part 2. Fetuin-A–A Marker of Insulin Resistance and Related …

RS Komsa-Penkova, KS Kovacheva… - Journal of Biomedical …, 2018 - sciendo.com
Fetuin-A is a secretory liver glycoprotein with multiple physiological functions such as
regulation of insulin resistance, tissue calcification, bone metabolism, cellular proteolytic …

[HTML][HTML] Plasma fetuin-A/α2-HS-glycoprotein correlates negatively with inflammatory cytokines, chemokines and activation biomarkers in individuals with type-2 …

S Sindhu, N Akhter, S Shenouda, A Wilson, R Ahmad - BMC immunology, 2016 - Springer
Abstract Background Fetuin-A/AHSH is a novel hepatokine that acts as a vascular
calcification inhibitor and as an endogenous TLR-4 ligand. Fetuin-A may act as a positive or …

[PDF][PDF] Fetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature

AM Dabrowska, JS Tarach… - Biomed Pap Med …, 2015 - biomed.papers.upol.cz
Background. Fetuin-A, also called Alpha 2-Heremans Schmid Glycoprotein, is a
multifunctional plasma agent what has been proven in animal and human studies. It plays a …

Proinflammatory and antiinflammatory attributes of fetu Iν-A: a novel hepatokine modulating cardiovascular and glycemic outcomes in metabolic syndrome

S Mukhopadhyay, SA Mondal, M Kumar, D Dutta - Endocrine practice, 2014 - Elsevier
Objective Fetuin-A is a novel hepatokine. The number of biologic roles attributed to fetuin-A
has increased exponentially in the past decade. The objective of this review is to discuss the …

Clinical implications of fetuin-A

P Jirak, L Stechemesser, E Moré, M Franzen… - Advances in clinical …, 2019 - Elsevier
Fetuin-A, also termed alpha2-Heremans-Schmid glycoprotein, is a 46 kDa hepatocyte
derived protein (hepatokine) and serves multifaceted functions.(i) It acts as systemic inhibitor …

Serum fetuin-A levels in obese and non-obese subjects with and without type 2 diabetes mellitus

Z Zhou, H Ju, M Sun, H Chen, Q Fu, D Jiang - Clinica Chimica Acta, 2018 - Elsevier
Background Higher fetuin-A expression is linked to both obesity and type 2 diabetes mellitus
(T2DM), However, studies in non-obese patients with T2DM are scarce. Methods 345 newly …

Plasma fetuin-A triggers inflammatory changes in macrophages and adipocytes by acting as an adaptor protein between NEFA and TLR-4

S Mukhopadhyay, S Bhattacharya - Diabetologia, 2016 - Springer
To the Editor: We read with interest the research letter entitled 'Plasma fetuin-A does not
correlate with monocyte TLR4 in humans' by Jialal and colleagues [1]. The authors state …

Effects of fetuin-A with diverse functions and multiple mechanisms on human health

MA Icer, H Yıldıran - Clinical biochemistry, 2021 - Elsevier
Abstract Fetuin-A (Alfa 2-Heremans-Schmid) is a glycoprotein that is mainly synthesized by
hepatocytes and then released into the bloodstream. While fetuin-A, a multifunctional …